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ABSTRACT

Majidi, Nasrin. M.S., Department of Biological Sciences, Microbiology and Immunology
Program, Wright State University, 2009. A potential strategy to maintain HSV-1 in a
latent state: use of immunoregulatory peptide mimetics.

This study reviews the role of interferon-gamma (IFN-γ) in HSV-1 latency. CD8+ T
cells inhibit the reactivation of HSV-1 in trigeminal ganglia (TG) by production of IFN-γ.
Although CD8+ T cells include all the cytotoxic apparatus for cytotoxicity, latently
infected neuronal cells are not killed by CD8+ T cells. The CD94-NKG2a molecule on
CD8+ T cells, binds to Qa-1b (a MHC class I like molecule) present on neuronal cell to
inhibit CD8+ T cells cytotoxicity.
Other studies have also determined that the IFN-γ peptide mimetic 95-132 inhibits
HSV-1 replication in the same way as IFN-γ in infected cells. IFN-γ mimetic peptide binds
to intracellular domain of interferon gamma receptor-1 (IFNGR-1) and initiates IFN-γ
signal transduction to the nucleus for gene activation. IFN-γ mimetic also is more active
than IFN-γ in gamma activated sequences (GAS) promoter.
Epithelial cells such as keratinocytes are the major target cell for HSV-1 replication.
In a murine keratinocyte cell line (HEL-30), suppressor of cytokine signaling-1 (SOCS-1)
prevents the antiviral activity of IFN-γ by inhibition of the JAK/STAT signaling pathway.
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Objective

To review the literature concerning HSV-1 latency and potential strategies to prevent
reactivation of HSV-1 from latency in trigeminal neurons (TGNs).
I. Herpes simplex virus infection and replication
Herpes Simplex Virus
Herpes simplex virus is an alpha herpes virus of the herpesviridae family. HSV-1
causes fever blisters or cold sore infection in humans. Most people get infected when
exposed to the virus, and recover completely from primary infection. Most primary
infections with HSV-1are without visible symptoms. Neuronal cells are susceptible
targets to be attacked by HSV-1 and virus will remain in them throughout the human’s
life span. Reactivation of HSV-1 may cause herpes encephalitis. Some stimuli such as
stress may induce viral gene reactivation. Production and assembly of viral particles
overcome the body’s immune system and leads to secondary infection (6, 9, and 16).
HSV-1 structure
Herpes simplex viruses are enveloped viruses. The envelope consists of different
glycoproteins (gB, gC, gD, gE, gG, gH, gI, gK, gL, gM) which are responsible for
attachment to the cellular receptors. The inner layer of the virus is the capsid made of
capsomeres about 100-200 nm in diameter with an icosahedral nucleocapsid. The space
between the envelope and the capsid is called the tegument. The tegument contains
proteins and enzymes which are involved in the virus replication (9).
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Linear double stranded DNA contains three classes of genes: Immediate early (IE) genes,
early (E) genes, and late (L) genes. Immediate early genes regulate expression of other
herpes virus genes (9).
Infected cell protein null (ICP0) and ICP4 are two products of IE genes. ICP0 (a
promiscuous transactivator of gene expression that it is required for both efficient
initiation of lytic infection and reactivation from latency) and ICP4 have an important
role in the early (E) and the late (L) genes expression. Early genes arrange the stage for
viral DNA replication and late gene activation. Expression of late genes encodes viral
structural proteins. Low-level expression of immediate early (IE) and early (E) viral
genes during latency inhibits the virus replication which induces a chronic immune
response. ICP0 and ICP4 could not be expressed in latently infected TGs. Latency
associate transcript (LAT) with sequence antisense to ICP0 blocks ICP0-mediated virus
replication and induce latency in neuronal cell. In contrast, expression of ICP0 or ICP4 in
early stage of infection induces virus replication (lytic infection) in infected cell (2, 9).
HSV-1 entry to the host cell
As shown in Figure 1, HSV-1 infects host cells by interfering with glycoprotein gB
or gC, to the cell receptor heparan sulphate. In the next step, binding of one herpes virus
entry protein (HveA, HveC and HveB) to the glycoprotein gD causes conformational
change. This conformational change allows gD to bind to gB or gH-gL dimmer.
Following this interaction, virus fusion occurs through host cell plasma membrane (9).
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Svend Ellermann-Erikson. Virol. J, 2005, 2:59 doi: 101186/1743-422x-2-59
Figure 1. Electron micrograph of HSV-1 structure and glycoproteins involved in adsorption of virus to the
host cell. 1= Important mediator of HSV-1 entry to the host cells. 2= receptors interaction. 3= membrane
fusion (Adapted from 9).

HSV-1 replication
HSV-1 proteins (α,β,γ) are produced during virus replication. Virus recruits cellular
RNA polymerase II for its gene transcription. Immediate early (IE) genes express α
proteins, which then induce early gene expression. Tegument proteins such as α-transinducing factor (α-TIF) initiates immediate early gene transcription. Expression of these
three gene classes results in assembly of virus particles which bud from the host cell. In
contrast, induction of latency associate transcripts (LATs) leads the virus toward latency.
LAT suppress IE genes during HSV-1 primary infection and facilitate latency in neuronal
cells. Another tegument protein which has important role in virus replication is virus
host shut off protein (vhs). This protein shuts off the host cell production machinery and
3

recruits it for its own replication. Late protein expression forms capsid and receptors on
the surface of the virus. Assembly of virus particles including genome, core and capsid
occurs in the nucleus of the cell. The virus envelope is created by budding into the inner
nuclear membrane of the cell (2, 6, and 9).
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II. Anti viral host defense
Cellular response in primary infection with HSV-1
HSV-1 primary infection induces an acute response during the first days of
infection. Natural killer (NK) cells and macrophages are two major cell groups that
produce IFNs in early defense against HSV-1 infection.
During first few hours macrophages produce cytokines such as IFN type I (IFNα/β), TNF, and IL-12. These cytokine products stimulate more macrophages to produce
reactive oxygen species (ROS) which have a direct antiviral effect. Depletion of these
cytokines enhances mortality of mice treated with HSV-1. Each cytokine gene expression
is induced through a particular signaling pathway. For example, signaling of IFNα/β
gene activation is induced by NF-κB family transcription factors. NF-κB is an
intracellular transcription factor which interacts with intracellular domain of toll like
receptors (TLR2, TLR3, and TLR9), IL-1R, and TNFR and transfers the signal to the
nucleus for IFNα/β gene activation (9). HSV-1 transcripts (i.e. LAT or ICP27) are related
to cytokine expression in acute infection. Immediately after HSV-1 infection, IE and E
genes produce their protein. Each of these proteins could induce cytokine production (2,
7, and 9).
As discussed previously, type I IFN and TNF are secreted immediately after HSV1 infection in host cells. A few hours after these are produced, macrophages react with
the HSV-1 by producing IL-12. As shown in figure 2, production of IL-12, IL-18, TNF
and IFNα/β by macrophages will induce IFN-γ production in NK cells. IFN-γ later
induces macrophages to produce more IFN-α/β, TNF and IL-12. IFNα/β and TNF
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negatively regulate IL-12 production in macrophages. Nitric oxide (NO) produced by
macrophages exerts direct anti viral activity. In Figure 2, note that IFN-α and IFN-β may
have direct effect on HSV-1 infection. ELISA analysis of TGs infected with HSV-1 also
demonstrated that IL-2, IL-6, IL-10, and IFN-γ proteins were present in acutely infected
TGs (7, 9).

Svend Ellermann-Erikson. J viral, 2005, 2:59 doi: 101186/1743-422x-2-59.
Figure 2. Production of cytokines during HSV infection in macrophages and NK cells (Adapted from 9).

IFN signaling pathway
Interferon plays an important role in the antiviral activity of target cells in HSV-1
infection. Interferons are produced by different cell types including NK and macrophages
cells in first line of host defense. IFN-γ produced by CD8+ T cells is effective against
HSV-1 infection in adaptive immunity. IFN-γ binds to its specific receptors on the target
cells and stimulates gene transcription. All type I IFNs (IFN-α/β) bind only to
6

IFNAR1/IFNAR2 whereas the Type II (IFN-γ) receptors are composed of two peptide
chains IFNGR1 and IFNGR2 (23, 24). IFN-γ signaling begins with interaction of IFN-γ
with an IFN receptor complex consisting of two IFNGR1molecules and two IFNGR2
molecules (23).
The C-terminus of IFN-γ consists of a nuclear localization sequence (NLS), which
plays an important role in binding of IFN-γ to IFNGRs. Endocytosis of IFNγ into the cell
occurs with interaction of IFN-γ NLS domain to IFNGR1. NLS domain also can bind to
IFNGR1 intracellular domain and induce JAK2 phosphorylation in tyrosine residue (19,
24). Autophosphorylation of JAK2 will induce activation and phosphorylation of
STAT1α. Following this induction, STAT1α transfers signal through mediators such as
importin-α5 (IMPα5) to the nucleus. Each cytokine has a particular signaling pathway.
IFNs (type I and II) select their specific pair of janus kinase (JAK) and signal
transduction and transcription (STAT) group for translocation of the signal to the
nucleus. For example IFN-α/β receptor complex recruit JAK1/Tyk2 for functioning,
while IFN-γ employs JAK2/STAT1α for the signaling pathway (5, 9, 19, and 24).
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Figure 3. IFN type I (α, β, κ, εε, and ω) and IFN type II (IFN-γ) signaling pathway.
(Adapted from Google images)
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Based on the role of IFN-γ in the inhibition of HSV-1 that is determined by various
studies, investigators sought to develop an IFN mimetic peptide which may inhibit HSV1 infection in the same manner as IFN-γ (20). Most experiments have demonstrated that
IFN-γ mimetic is even more active than IFN-γ (22). IFN-γ mimetic peptide consists of Nterminal and C-terminal units, which the C-terminal consists of nuclear localization
sequence (NLS) region. C-terminal of IFN-γ is necessary for IFN-γ mimetic function
(19). NLS region does not have antiviral activity itself. Lipophilic group are also added to
IFN-γ C-terminal for cell penetration. C-terminal of IFN-γ binds to intracellular domain
of receptor while N-terminal binds to extracellular domain (19).
Viruses have some strategies to escape from immune response. For example, vaccinia
virus produces B8R protein (a virulence factor of poxviruses) to evade from the host
immune response (18). B8R virulence factor which is a homology of extracellular
domain of IFNGR1 binds to IFN-γ and prevents its interaction with IFNGR1 on the cell
surface. IFN-γ peptide mimetic is a small peptide with attached lipo- palmitate in Cterminal for the cell penetration. This peptide binds to intracellular domain of IFNGR1
and initiates the IFN-γ signaling path way through phosphorylation of JAK2/STAT1α
(20, 21).
SOCS-1 expression suppresses the IFN-γγ activity
HSV-1 uses suppressor of cytokine signaling (SOCS) proteins to fight on immune
response. These protein products are inducible when IFN-γ binds to its receptor on the
cell surface and negatively regulates IFN-γ antiviral activity in HSV-1 infection. The
SOCS family include 7 members; SOCS1, SOCS2, SOCS3, SOCS4, SOCS5, SOCS6,
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and SOCS7. SOCS has a kinase inhibitory region (KIR) and src homology 2 (SH2)
domains which are very important in binding of SOCS-1 to JAK2. The binding of KIR
region to JAK2 tyrosine residue inhibits the autophosphorylation of STAT1α. Inhibition
of STAT1α autophosphorylation results in IFN-γ signaling path way shut off. Using a
SOCS mimetic or tyrosine kinase inhibitory peptide (Tkip) in HSV-1 infection showed
this peptide mimetic is able to bind to tyrosine residue of JAK2 and prevents STAT1α
phosphorylation in IFN-γ signaling pathway. This observation led the investigators to
develop a SOCS antagonist that blocks SOCS activity produced by virus. SOCS-1
peptide antagonist binds to KIR region of SOCS-1 and allows JAK2 phosphorylation and
subsequently STAT1α phosphorylation and IFN-γ signaling pathway continues (23, 24,
25, 26, and 27).
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III. HSV-1 latency
Cellular interactions in HSV-1 latent infection in Trigeminal Ganglia (TG)
After primary infection, HSV-1 persists in neural ganglia throughout human life
span. During latent state, HSV-1 produces latency associate transcript (LAT) mRNA.
Immediate early (IE) and early (E) genes expressions are very low. This low level of α
and β proteins are essential to induce CD8+ T cells activity. CD8+ antigen specific T
cells with IFN-γ production capacity are the major immune cells in trigeminal ganglia
(TG). These cells inhibit the viral replication in neuron cells without any cell destruction
(1, 6).
Chemokines such as IP-10 and RANTES are present in Trigeminal Ganglia (TG),
and recruit other immune cells to defeat active HSV-1infection (12). All these factors
together overwhelm the virus replication and keep it in a latent state. The reason that
neurons are susceptible to HSV-1infection could be the low level expression of MHC
molecules (1). Neuronal cells with transient expression of MHC class I molecules are
able to present the virus antigen to CD8+ T cells (1).
Cellular immunity including CD8+ Tcells, CD4+ T cells and γ/δ T cells are essential
to fight HSV-1 infection in TG. CD8+ T cells do not eradicate HSV-1 with their
cytotoxic effect in neuronal cells. CD8+ T cells also defeat HSV-1by its non lytic
activation in primary infection. In latent state, neuron cells infected with HSV-1 will not
be killed by CD8+ T cells, because CD8+ T cells use their nonlytic mechanism only to
overcome HSV-1 replication in latent state. Although CD8+ T cells contain lytic
granules, they are not able to kill neuronal cells (1, 6).
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This observation guided Suvas (1) and colleagues to ask whether other mechanisms
such as cellular interaction could be involved in the CD8+ T cells function (1). For this
purpose they infected female 6 to 8 weeks old C57Bl/6 (B6) mice with HSV-1. TG were
removed 28 days after ocular infection and flow cytometry used for cell surface and
intracellular staining of the neuron nucleus. Granzym B (induces apoptosis in viral
infected cells) and perforin (cytolytic protein) were expressed in CD8+ T cells isolated
from TG. They also examined the expression of NK inhibitory receptors on T-cells. The
result showed 65% of Ag-specific CD8+ T cells express NKG2a (1).
In next experiment the expression of CD94 molecule (inhibitory receptor) on
CD8+T cells also examined. NKG2a functions when co-expressed with CD94 on CD8+
T cells. Results showed 80% of the CD8+Tcells positive for NKG2a expressed CD94
molecule. They hypothesized interaction of CD94/NKG2a and Qa-1b (a MHC class I like
molecule) on neuronal cells may blocks cytolytic activity of CD8+Tcells.Therefore they
used MC-38 (a colon carcinoma cell) as target cell to show Qa-1b expression. As shown
in Figure 4a ~ 50% of MC-38 cells were able to express Qa-1b molecule (1).
In the next experiment, an immunogenic peptide derived from HSV-1 (SSIEFAR)
was added in two different concentrations (2.0 and 0.2 µM) to target cells (MC-38 cells)
that were co-cultured with CD8+ T cells. This system was used to determine the level of
cytotoxicity of CD8+ T cells for the HSV-1 peptide. Cells treated with both
concentrations showed significant cell lysis in the presence of the CD8 + T cells. As
shown in Figure 4b, blocking of the CD94-NKG2a-Qa1b interaction increased CPE of
target cells (using anti-Qa-1b Ab). These result demonstrated that, in spite of expression
of lytic granules in HSV-specific CD8+Tcells for the treated carcinoma cell line, these
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CD8+ T cells could not destroy the cultured neuronal cells due to CD94-NKG2a-Qa1b
interaction (1).

Figure 4. The effect of Qa-1b-CD94/NKG2a interaction blockage on the CD8+ Tcells cytotoxicity. a,
Using target cells MC-38 (a colon carcinoma cell line) for the expression of Qa-1b molecule. b. The effect
of anti-Qa-1b on cell lysis (Adapted from 1).

Co-expression of CD94/NKG2a on HSV-1 CD8+ specific T cells could be induced
by transforming growth factor β1 (TGF-β1), which is present in TG after HSV-1
infection. The presence of CD4+CD25+ reg (regulatory) T cells in TG could be a
possible source of TGF-β1. To determine whether CD4+ CD25+ T reg cells play a role in
TGF-β1 expression in latent infection of TG, B6 mice were treated (28 days p.i.) with a
monoclonal antibody (PC61) to deplete endogenous CD25+T cells. The level of TGF-β1
protein was decreased in CD4+CD25+ T cells depleted TG culture. This treatment almost
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completely depleted TGs of CD4+CD25+ T cells. Regulatory CD4+Foxp3+ T cells
(∼4%), another source of TGF-β, were expressed in the latent TG of such treated animals.
Therefore CD4+ CD25+ T reg cells may play an important role in induction of CD8+ T
cells cytotoxicity (1).

Cytokines in latently infected TG models
Ocular infection with HSV-1 results a latent infection in mice. Lymphocytes persist
in TG producing of cytokines that maintain the virus in non replicating state. If immune
system was not able to clear HSV-1from the body, virus moves to central nervous system
and may cause fetal encephalitis (an acute inflammation of brain) (7).
Halford and colleagues (7) hypothesized that the cytokines expression in TG may
have some effect on fetal encephalitis. They infected ICR mice by corneal inoculation
with HSV-1 and six to nine days later 4 of 5 mice died with fetal encephalitis. Cytokine
transcript expression (especially IL-10 and IFN-γ mRNAs) was strongly up-regulated in
acutely infected TG 5 days post inoculation (PI). RT-PCR detection of LAT RNA was
used to confirm that TGs were infected with HSV-1. ICP27 is a α gene production which
is necessary for HSV-1 infection. Therefore the presence or absence of ICP27 mRNA
would confirm the virus is in latent or active state, respectively in this experiment ICP27
mRNA was not detected. Thus the replication of virus was inhibited by cytokine
expression in some way in TG (7).
Within TG cytokines such as TNF-α, IL-6 IFN-γ inhibit HSV-1 reactivation. TNF-α
is also produced in the innate response against HSV-1 by macrophages and NK cell (8).
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To study whether the depletion of this cytokine has any effect on disease severity,
Minagawa and colleagues (8) examined the effect of neutralizing specific
proinflammatory cytokines on HSV-1 reactivation from TG explants. They examined the
effect of TNF depletion in HSV-1 reactivation both in vitro, and in vivo in TNF-knockout
mice (8). BALB/C mice 5-6 weeks of age were inoculated with HSV-1 in both eyes, and
after 8 weeks TG removed from mice and added to fresh medium. Samples were taken
from TG cultures and added to Vero cells to monitor the cytopathic effect (CPE) in vitro.
As shown in Figure 5, depletion of TNF in the cell culture resulted in virus reactivation,
which was significant when compared with control. In contrast, adding anti-IL6 had no
effect on virus reactivation (8).
They did the same study in vivo on B6 mice, which are more resistant to HSV-1
infection than BALB/C mice. B6 TNF knock-out mice were infected with HSV-1 and
survival percentage monitored. In TNF-knockout mice the survival percentage dropped to
0-40%. Therefore using TNF-KO mice showed that TNF has an important role in the
body’s immune system against HSV-1 reactivation in TG (8).
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Figure 5. The effect of TNF and IL-6 depletion on reactivation of HSV-1. TG explants were depleted from
IL-6 or TNF using specific antibodies and the HSV-1 reactivation detected (Adapted from 8).

Effect of neutrophils on HSV-1 infection
Similar to T lymphocytes and macrophages, which are thought to be the major
cellular defense against HSV-1 infection, neutrophils also participate indirectly against
HSV-1 infection. Neutrophils produce chemokines such as interferon-inducible protein
10 (IP-10) and monokine induced by IFN-γ (Mig) that attract the other immune cells
(CD4+ and CXCR3+ expressing cells) to the site of infection. Molesworth-Kenyon and
colleagues (12) hypothesized that neutrophil depletion would have an inhibition effect on
cellular recruitment to the delayed type hypersensivity (DTH) site. BALB/c mice were
treated with HSV-1 via right cornea and DTH monitored by ear swelling assay.
Neutrophils depleted 9 days later by i.p. administration of monoclonal antibody (RB6
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8C5 Ab) in mice. On day 10, the mice were challenged in the ear pinna with HSV-1.
Figure 6 show that mAb RB6 8C5 mice treatment reduced the number of neutrophils at
the DTH site by 85%. CD4+ and CD8+ T cell recruitment was reduced significantly by
90% and 70%, respectively. Depletion of neutrophils also resulted in a 73% reduction in
cells expressing the chemokine receptor CXCR3. Therefore neutrophils synergize with
the other immune cells such as CD4+, CD8+ T cells in preventing HSV-1 infection. (12).

Figure 6. Depletion of neutrophils, reduced the number of immune cell infiltration to the DTH site. The
number of infiltrating neutrophils, CD4+Tcells, CD8+ T cells, and CXCR3+ cells determined by
immumohistochemical staining using appropriate antibodies and compared with control IgA (Adapted from
12).
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IV. Using peptide mimetic for antiviral activity
Antiviral activity of IFN-γγ mimetic peptide
NLS domain of IFN-γ interacts with cytoplasmic domain of IFNGR1 and
phosphorylates JAK2 in tyrosine residue, this autophosphorylation induces STAT1α
activation. In the next step, the complex (IFN-γ/IFNGR1/JAK2/ STAT1a) associates with
IMPα5 which later translocates to nucleus to activate gene transcription (22).
Fulcher and colleagues (22) hypothesized that the IFN-γ mimetic peptide has the
same affinity for IMPs as does IFN-γ in signal transduction to the nucleus. They
synthesized a mIFN-γ peptide mimetic with binding affinity to IMPs (Importins). Using
ELISA- based binding assay they showed that both IFN-γ and mIFN-γ had affinity to
IMPs (antibody specific to IMPα-GST). IFN-γ peptide mimetic even had more affinity to
IMPs compared to control T-ag 111-135-β-gal (22).
In the next experiment, they used plamids to transfect of mIFN-γ mimetic and IFNγ which were bound to firefly luciferase to activate GAS promoter. As shown in Figure
7, mIFN-γ peptide mimetic was more active than IFN-γ in activating the IFN-γ activated
site (GAS) promoter (by measuring of luciferase activity). These results demonstrated
that high affinity of IMPα/β for mIFN-γ mimetic leads to activation of GAS promoter
and gene transcription (22).
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Figure 7. Use of IFN-γ mimetic or IFN-γ to activate GAS promoter. Plasmids expressing non-secreted IFNγ or IFN-γ mimetic peptide were transfected into WISH cells together with a reporter plasmid. Using 200
ng of IFN-γ and IFN-γ mimetic showed higher GAS promoter activity. 50 ng determined lower activity. In
both concentrations IFN-γ mimetic was more active than IFN-γ (Adapted from 22).

The effect of vaccinia virus virulence factor B8R on IFN-γγ
Viruses exert various strategies to escape from host immune responses. IFN-γ has
an important role in host antiviral activity in various viral infections such as HSV-1 and
vaccinia virus infections. B8R protein (a virulence factor and homology of extracellular
domain of IFNGR1) produced by vaccinia virus binds to IFN-γ and prevents its
attachment to extracellular domain of IFNGR1 on target cell. IFN-γ mimetic peptide is a
small peptide with lipo-palmitate attached to C-terminal for cell penetration. This peptide
is able to penetrate to the cell and bind to the intracellular domain of IFNGR1 and
initiates the IFN-γ signaling pathway in vaccinia virus and other viruses such as HSV1(18).
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Ahmed and colleagues (18) hypothesized that a synthesized IFN-γ peptide mimetic which
binds to intracellular domain of IFNGR1 and induce phosphorylation of JAK/STAT
mediators may block the B8R activity (18).
They synthesized a small IFN-γ mimetic peptide (mIFN-γ) 95-132 for mice. C57BL/6
mice treated with different doses of lipo-mimetic IFN-γ 95-132, non-lipomimetic (lipophilic
palmitate is absent for cell penetration) and lipo control (NLS is absent for binding to
intracellular domain of IFNGR1) i.p., and then the mice were challenged with vaccine
virus with B8R production potential. As shown in Figure 8 mice were completely
protected with 200 µg, but protection with 50, 15, and 5 µg decreased to 80, 80, and 40%,
respectively. Mice were not protected with non-lipo mimetic and lipo-control treatment.
This approach led the investigators to design an IFN-γ mimetic peptide therapy for
humans infected with vaccinia virus and other viruses (18).

Figure 8. mIFN-γ 95-132 role in the protection of mice against encephalomycarditis caused by vaccinia
virus. Different doses of lipo-mimetic IFN-γ 95-125 were given to C57BL/6 mice (5, 15, 50, 200 µg) and
then challenged with vaccinia virus and mice survival percentage followed (Adapted from 18).
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Tkip negatively regulates cytokine signaling path way
IFN-γ binds to its receptor (IFNGR1) on the cell and autophosphorylats JAK2.
Suppressor of cytokine signaling 1SOCS-1 binds to JAK tyrosine residue and inhibits
STAT1 autophosphorylation which leads to blockage of IFN-γ signaling pathway (21).
The abnormal phosphorylation of JAK tyrosine kinase region also causes
inflammatory diseases such as experimental allergic encephalomyelitis (EAE) (an animal
model for multiple sclerosis). To confirm this hypothesis Mujtaba and colleagues (21)
developed a tyrosine kinase inhibitory peptide (Tkip) which has 12 residues
(WLVFFVIFYIFYFFR) which bind to the tyrosine kinase residue of JAK2 and makes it
inaccessible for binding of STAT1α. For this experiment, Tkip and IFN-γ 95-125 peptides
were synthesized and acute EAE induced in NZW mice. Then lipo-Tkip, lipo-IFN-γ 95-133
was given to mice i.p. and the severity of disease was monitored. As shown in figure 9,
Tkip treated mice did not develop acute EAE. In contrast mice treated only with PBS are
not protected. Therefore using Tkip could be useful to control inflammatory diseases
such as EAE (21).
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Figure 9. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, Tkip, prevents
development of the acute form of EAE. NZW mice were treated with Tkip i.p. Control mice received PBS.
All of the BPS mice developed EAE (Adapted from 21).

SOCS-1 KIR and Tkip inhibit IFN-y induced macrophages activity
Tkip binds to JAK2 autophosphorylation site and prevents STAT1α binding and
subsequent phosphrylation (23). The prevention of STAT1α phosphorylation results in
inhibition of activation of further mediators, and IFN-γ signal transduction path way will
be halted. Similar to Tkip, SOCS-1 KIR recognizes the JAK2 tyrosine region for its
function and follows the pathway discussed above. To confirm this hypothesis, Waiboci
and associates (23) sought to show both SOCS-1-KIR and Tkip bind to JAK2
autophosphorylation site and prevent binding and autophosphorylation of STAT1a. For
this purpose, they immobilized SOCS-1-KIR, Tkip, and control peptide on 96-well micro
titer plates and incubated with JAK2 (1001-1013). Binding assays showed both SOCS1KIR and Tkip bound to JAK2 autophosphorylation site (23). In the next experiment, they
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showed SOCS1-KIR and Tkip inhibited cytokine signaling through blocking of STAT1α
phosphrylation in murine U937 cells (immunoblot analysis of STAT1α). Macrophages
have a key role in antiviral resistance, and are inducible by IFN-γ. The macrophage cell
line Raw 264.7 was activated by IFN-γ and SOCS1-KIR or Tkip were then used to
determine if they are able to block nitrite oxide (NO) production by macrophages. Figure
10 shows both Tkip and SOCS1-KIR inhibited the NO production. The SOCS1
antagonist may provide a therapeutic strategy for viral infections (23).

Figure 10. The role of TKip or SOCS-1 in induction of NO by various concentrations of IFN-γ in
macrophages. Raw 264.7 macrophages were incubated with different concentration of IFN-γ alone or in the
presence of either Lipo Tkip, Lipo SOCS1-KIR or control. Nitrite concentration determined using Griess
reagent (Adapted from 23).
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IFN signal transduction is inhibited by over expression of SOCS
Yokota and colleagues (24) demonstrated that SOCS3, member of SOCS family,
inhibits IFN-α signal transduction through blocking of JAK/STAT path way in the same
manner as SOCS-1. They used defective HSV-1 (mutated in tegument proteins UL41 and
UL13) and wild type (VR3). Human amnion cell line FL was infected with HSV-1 wild
type (VR3) or defective d41 or d13, and then treated with INF-α to examine the effect of
SOCS3 on STAT1 phosphorylation. SOCS3 produced by wild type VR3 inhibited the
phosphrylation of JAK2 /STAT1. In contrast, mutated strains d41 or d13 could not
prevent STAT1 phosphorylation completely (24).
They also sought to show whether over expression of SOCS3 in FL cell culture has
the same result. FL cell culture was transfected with the pSOCS3 expression plasmid.
Shown in Figure 11A is SOCS3 expression in the cultures transfected with pSOCS3
expression plasmid. After 24 h, transfected cells were treated with IFN-α. Western blot
showed STAT1 phosphorylation was inhibited in SOCS3 over expressed cells. These
results determined HSV-1 uses SOCS3 in the same strategies as SOCS1 for its antiviral
function (24).

Figure 11. IFN signal transduction is inhibited by over expression of SOCS3. Over expression of SOCS3 in
FL cells with pSOCS3 expression plasmid and then treated them with IFN-α. IFN-α-induced STAT1
phosphorylation was inhibited in cells transfected with pSOCS3 (Adapted from 24).

24

The role of IFN-γγ anti viral activity in fibroblast (L-929) or Keratinocytes (HEL-30)
Epithelial cells such as keratinocytes are the major target cells for HSV-1 replication.
To determine why HSV-1 targets keratniocyte cell line for its replication, Frey and
associates (27) considered keratinocyte and fibroblast cell lines for their experiments. As
discussed before, IFN-γ is an effective cytokine against HSV-1 infection. Therefore,
induction of this cytokine in the cell infected with HSV-1 would have some benefits to
protect cell from virus destruction. They treated keratinocytes (HEL-30) and fibroblast
(L-929) cells with murine IFN-γ or IFN-γ peptide mimetic, and then these cell cultures
were infected with HSV-1. Two to three days post infection cell survival observed. As
shown in figure 12 IFN-γ protected fibroblasts cells from HSV-1 infection in 50, 25, 12.5
and 6.25 concentration, but this protection was abrogated with the same concentration in
HSV-1 infected keratinocytes (27).

Figure12. The effect of IFN-γ on L929 fibroblasts (a) or HEL-30 keratinocytes (b) infected with HSV-.
Recombinant murine IFN-γ added to the cultures at the concentration of 12.5 to 50, and cells lysis was
monitored (Adapted from 27).
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They hypothesized that the IFN-γ signaling may be obstructed somewhere in the cell
signaling pathway. They developed a small peptide mimetic of mouse IFN-γ (95132).This synthetic mimetic peptide could penetrate the plasma membrane via palmitate
attached to C-terminal. The mimetic peptide was able to activate JAK/STAT transduction
pathway in the same manner as IFN-γ (discussed in previous studies). Using mimetic
IFN-γ peptide in keratinocytes (HEL-30) or fibroblasts (L-929), HSV-1 replication was
inhibited only in fibroblasts, but not in keratinocytes (27).

Figure13. The effect of IFN-γ mimetic peptide (95-132) on Fibroblasts cells L929 (a) and Keratinocytes
HEL-30 (b). L929 and HEL-30 treated with IFN-γ mimetic at the indicated concentration. The effect of
IFN-γ mimetic on L929 and HEL-30 cells determined based on cell survival (Adapted from 27).

Since several studies have determined SOCS negatively regulates the IFN-γ activity. Frey
and colleagues hypothesized that SOCS-1 may inhibits IFN-γ antiviral activity in
keratinocytes. HEL-30 keratinocytes and L929 fibroblasts were infected with HSV-1 and
SOCS-1 expression detected by Western blot analysis. As shown in figure 14,
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keratinocytes (HEL-30 cells) expressed of SOCS-1 mRNA, while infected fibroblast cells
did not show SOCS-1 mRNA expression. HSV-1 induces SOCS-1 expression in
keratinocytes (HEL-30 cells), but not in fibroblasts (L929 cells) (27).

HEL-30
L929

HEL-30
L929

Figure 14. RT –PCR analysis of SOCS-1 mRNA expression in HSV-1 infected fibroblasts and
keratinocytes. HEL-30 and L929 cells were infected with HSV-1. Total RNA was extracted and used as a
template for RT-PCR using primers specific for SOCS-1 or GAPDH as a control (Adapted from 27).

STAT-1α
α phosphorylated by IFN-γγ induction in fibroblasts (L-929) but inhibited in
keratinocytes (HEL-30)
They suggested SOCS1induced by HSV-1in keratinocytes may bind to JAK2 by its KIR
(kinase inhibitory regeon) and prevents JAK2 phosphrylation and finally blocks the IFNγ signal transduction. To confirm this suggestion, IFN-γ -treated keratinocytes or
fibroblasts were infected with HSV-1, and STAT1α phosphorylation detected. As shown
in Figure15 L-929 cells expressed pSTAT1α phosphorylation, but HEL-30 cells did not.
This demonstrates that HSV-1 employs SOCS-1 to inhibit HSV-1 antiviral activity in
keratinocytes but not in fibroblasts (27).
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Figure 15. STAT1α activation by IFN-γ inhibited in HEL-30 cells (a) but not in L929 cells (b). HEL-30 or
L929 were treated with HSV-1. Some of the infected cells were also treated with IFN-γ and expression of
STAT1α detected (Adapted from 27).

A peptide antagonist of SOCS-1 reduces HSV-1 induced CPE in HEL-30
The role of SOCS-1 was established in inhibition of IFN-γ antiviral activity. SOCS-1
binds to JAK2 and prevents its phosphorylation. Subsequently, they synthesized an
antagonist of SOCS-1 which binds to the kinase inhibitory region (KIR) of SOCS-1 and
prevents the binding of SOCS-1 to JAK2. Therefore JAK2 phosphorylates STAT1α and
IFN-γ signaling pathway will be continued. HEL-30 cells were cultured and then treated
with IFN-γ . Different concentration of pJAK2 added to HEL-30 cultures and then cells
were infected with HSV-1. As shown in Figure 16 HEL-30 cells treated with
35µM pJAK2 were completely survived from HSV-1 infection. HEL-30 cell survival
dropped to 75% and 25% with 17 and 8 µM concentration of pJAK2, respectively (27).
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Figure 16. Using a peptide antagonist of SOCS-1 in HSV-1 infected HEL-30 cells. HEL-30cells were
treated with IFN-γ alone, or different concentrations of pJAK2 with or without 100U/ml of IFN-γ. Then
cells were infected with HSV-1 and HSV-1 induced CPE monitored (Adapted from 27).

Over expression of SOCS-1 inhibits the anti-viral activity of IFN-γγ in HSV-1
infected L929 cells
Expression of SOCS-1α significantly decreased the antiviral activity of IFN-γ in
HEL-30 keratinocytes cells infected with HSV-1. This suggests overexpression of SOCS1α may have the same effect in the L929 cell lines. Therefore, a tyrosine kinase inhibitor
peptide (Tkip) (a SOCS-1 mimetic peptide) was developed. This small peptide
(WLVFFVIFYFFR) and Tkip2 (alanine was substituted with phenylalanine) was used to
transfect fibroblasts which were treated with IFN-γ and infected with HSV-1. L929
fibroblasts were cultured and then were transfected with control plasmid or pFLAGSOCS -1 plasmid. Cells then treated with IFN-γ and after 24 hours cells were infected
with HSV-1. Tkip prevented antiviral activity in fibroblast in the same manner as SOCS1did in keratinocytes. In contrast Tkip2 did not show any effect on IFN-γ antiviral
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activity (27). Therefore using SOCS-1 peptide antagonist could have some benefits in
persons infected with HSV-1 infection.

Control plasmid, µ g 0
SOCS-1 plasmid, µ g 0
IFNγγ
−

2
0
+

0
1
+

0
2
+

Figure 17. Overexpression of SOCS-1 in L929 cells inhibited IFN-γ anti viral activity. L929 fibroblasts
transfected with the indicated amounts of control plasmid or pFLAG-SOCS plasmid. Then cells treated
with 100 U/ml IFN/γ for 24 hours. Cells infected with HSV-1. HSV-1 induced CPE was measured
(Adapted from 27).
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Discussion
Herpes simplex virus 1 infection induces innate and adaptive immune responses (9).
NK cells and macrophages play an important role in clearing viruses from the body in the
first hours of the virus attack. In the innate response, proinflammatory cytokines such as
TNF-α, IFN type I (α&β) are involved (9). Nitric oxide (NO) produced by macrophages
also may act directly against HSV-1 in early HSV-1 infection. If innate immunity cannot
clear the virus from the body, adaptive immunity needs to be activated (9).
Cell mediated immunity, especially involving CD8+ T cells and CD4+ T cells, is
important in adaptive immunity (1, 7). Like other viruses HSV-1 replication takes place
in the cells. CD8+ T cells are able to destroy the cell infected with HSV-1 by cytotoxic
effect (6). After primary infection, HSV-1 moves to the neuronal cells and is retained in a
latent state. One reason why neuronal cells could be selected by the virus for replication
is the low level expression of MHC molecules (1). Transient expression of MHC class I
molecules on neuronal cells would induce CD8+ T cells to take action against HSV-1 (1).
Expression of HSV-1 immediate early genes such as ICP0, ICP4, and ICP27
induces early and late gene products, which finally leads to virus replication (7).
Expression or absence of ICP0, ICP4, ICP27 and LAT proteins has a pivotal role in virus
latency. Low level expression of α and β genes are essential for induction of immune
response against HSV-1 (7).
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CD8+ T cells produce IFN-γ to keep HSV-1 in a latent state without any cell
destruction (1). Suvas et al. (1) showed co-expression of CD94-NKG2a on CD8+ T cells
and interaction with Qa-1b molecule on neuronal cells that prevent the neuronal cell
destruction by CD8+ T cells. They showed the majority of Ag-specific CD8+ T cells
express NKG2a (65%) and CD94 molecules. MC-38 cells (a colon carcinoma cell line)
as target cells were examined for Qa-1b molecule expression and 50% of these cells were
able to express Qa-1b molecule (1).
An immunogenic peptide derived from HSV-1 (SSIEFAR) was added in two
different concentrations (2.0 and 0.2 µM) to target cells that were co-cultured with CD8+
T cells. This system was used to determine the level of cytotoxicity of CD8+T cells for
the HSV-1 peptide. Both concentrations showed significant cell lysis in the presence of
the CD8 +T cells. Blocking of the CD94-NKG2a-Qa1b interaction led to increased CPE
of target cells. These results demonstrated that, in spite of expression of lytic granules in
HSV-specific CD8+Tcells for the treated carcinoma cell line, these CD8+ T cells could
not destroy the cultured neuronal cells due to CD94-NKG2a-Qa1b interaction. This
interaction inhibits CD8+ T cell cytotoxicity and keeps HSV-1 in latency (1).
CD94 molecule expression on CD8+ T cells could be induced by TGF-β1 present in
TG (1). Depletion of CD4+ CD25+ cells resulted in severe disease in mice infected with
HSV-1 and also reduction of the percentage of TGF-β1 produced (1). Thus CD4+CD25+
cells have a pivotal role in CD8+ T cell cytotoxicity. Although mice were depleted
>90% from CD4+CD25+ T cells, the small remaining (4%) Foxp3 CD4+ cells in TG
may induce TGF-β1 expression. Therefore Foxp3 CD4+ cells may serve as another
source of TGF-β1 (1).
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Lymphocytes with cytokine production persist in TG to maintain HSV-1 in latency.
Halford et al. (7) showed that cytokine transcript expression (especially IL-10 and IFN-γ
mRNAs) was strongly up-regulated in TG 5 days post inoculation in ICR mice (7).
Cytokines IL-2, IL-10, IFN-γ, RANTES, and TNF-α mRNAs were detected in TG 14,
24, 35, 60 and 125 days p.i. by using RT-PCR analysis (7).
The HSV-1infection also was confirmed by detection of ICP27 gene expression.
ICP27 mRNA was not detected, but LAT RNA was expressed in TG, showing that virus
was in a non-replicating state. Thus lymphocytes with production of cytokines have
important role to maintain HSV-1 in latent state and prevent the reactivation of the virus
in TG (7).
Expression of cytokines expression such as TNF-α, IL-6, and IFN-γ inhibits HSV-1
reactivation in TG. TNF-α is also produced in the innate response against HSV-1 by
macrophages and NK cell (8). Minagawa and colleagues (8) examined the efficacy of
TNF-α depletion in HSV-1 reactivation both in TG culture, and in TNF-knockout mice.
They showed depletion of TNF-α in cell culture infected with HSV-1 increased virus
reactivation. In the in vivo experiment, the survival of TNF-KO mice infected with HSV1 dropped to 0% to 40%. Therefore this study confirmed that TNF- α also plays a pivotal
role to inhibit HSV-1 reactivation in TG (8).
Neutrophils also participate indirectly in the immune defense against HSV-1
infection. Molesworth-Kenyan and associates (12) demonstrated that the survival
percentage of BALB/c mice depleted of neutrophils significantly dropped. The number of
CD8+ T cells, CD4+ Tcells, neutrophils, and CXCR3+ expressing cells in DTH
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decreased in neutrophil depleted mice. They also showed neutrophil depletion decreased
the production of IP-10 and Mig in delayed type hypersensivity (DTH) (12).
Viruses employ tactics to escape from the host immune defense, for example
expression of virulence factor B8R by vaccinia virus impedes IFN-γ antiviral activity.
This protein binds to IFN-γ and inhibits its binding to the cell surface receptor. Ahmed
and colleagues (18) showed that a synthesized IFN-γ peptide mimetic bound to the
intracellular domain of IFNGR1 and induced phosphorylation of JAK/STAT mediators
and blocked the B8R activity. They treated C57BL/6 mice with different doses of mIFNγ 95-132, and then challenged with vaccinia virus with B8R production potential. Results
showed most mice were protected from death (18).
This approach led the investigators to design an IFN-γ mimetic peptide therapy for
the persons infected with vaccinia virus and other viruses. This finding may be useful in
clinical therapy to protect persons against diseases caused by vaccinia and other viruses
such as HSV-1(18).
IFN-γ produced by CD8+ T cells induces gene activation through internalization to
the cell by a specific signaling pathway. This pathway is initiated by binding of IFN-γ to
its specific receptor IFNGR1/IFNGR2. IFN-γ interaction with IFNGR1 leads to
JAK/STAT phosphorylation and finally activation of other signal mediators. This signal
will be transferred to the nucleus to initiate the GAS activation. IFN-γ NLS domain has
an important role in IFN-γ signaling pathway. IFN-γ and IFN-γ mimetic interact with
IMPα5 in cytosol through complex of IFN-γ-IFNGR1/phoshorylated STAT1α (22).
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Fulcher et al. (22) showed that the IFN-γ mimetic peptide has the same affinity for
IMPs as does IFN-γ in signal transduction to the nucleus. Using ELISA- based binding
assay they showed that both IFN-γ and mIFN-γ had affinity to IMPs (antibody specific to
IMPα-GST). They also explained mIFN-γ peptide mimetic was more active than IFN-γ in
activating the GAS promoter (by measuring of lucifrase activity). These results
demonstrated that high affinity of IMPα/β for mIFN-γ mimetic leads to more activation
of GAS promoter and gene activation. Thus IFN-γ mimetic peptide could be used in
future studies in place of IFN-γ (22).
Suppressor of cytokine signaling (SOCS) is a strategy employed by HSV-1 to
escape from immune system. SOCS binds to JAK2 autophosphorylation site via SOCSKIR (kinase inhibitor region). This binding prevents auto phosphorylation of STAT1α
and inhibits signal transduction. Abnormal phosphorylation of tyrosine region of kinases
causes some diseases, for example experimental allergic encephalomyelitis (EAE). Tkip
or SOCS mimetic peptide could have some benefits in protection of mice from EAE (21).
Mujtaba and colleagues (21) developed a tyrosine kinase inhibitory peptide (Tkip)
which has 12 residues (WLVFFVIFYIFYFFR) which binds to the tyrosine kinase residue
of JAK2 and makes it inaccessible for binding of STAT1α. They showed Tkip-treated
mice survived acute EAE. Therefore using Tkip could be useful to control inflammatory
diseases such as EAE (21).
SOCS-1 is used by HSV-1 to escape from body’s immune system. Similar to Tkip,
SOCS-1 KIR recognizes the JAK2 tyrosine region for its function. Waiboci and
associates (23) demonstrated both SOCS-1-KIR and Tkip bind to JAK2
autophosphorylation site and prevent binding and autophosphorylation of STAT1a (21).
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Binding assay showed both SOCS1-KIR and Tkip bound to JAK2
autophosphorylation site. Macrophages have a key role in anti viral resistance, and are
inducible by IFN-γ. They used macrophage cell line Raw 264.7 which was activated by
IFN-γ and SOCS1-KIR or Tkip were then used to determine if they are able to block NO
production by macrophages. Both Tkip and SOCS1-KIR inhibited the NO production.
Thus SOCS1 antagonist may provide a therapeutic strategy to inhibit virus replication by
prevention of SOCS1 function (23).
Using SOCS3 Yokota and colleagues (24) demonstrated that IFN-α signal
transduction pathway was blocked in JAK phosphorylation site in the same manner as
SOCS-1. They also showed overexpression of SOCS3 in FL cell culture had the same
result. Western blot showed STAT1 phosphrylation was inhibited in SOCS3 over
expressed cells. These results determined HSV-1 uses SOCS3 in the same strategies as
SOCS1 for its anti viral function (24).
Keratinocyte cells are the most important site for HSV-1 replication. The SOCS
family expression (SOCS1, SOCS2, SOCS5, and CIS) was highly increased in IFN-γ
infected keratinocytes. Frey et al. (27) showed IFN-γ inhibited the HSV-I infection in
fibroblasts but did not prevent the viral replication in keratinocytes. This is because of
SOCS-1 expression in keratinocytes cells but not in fibroblasts. Using SOCS-1 peptide
antagonist in keratinocytes increased the percentage of cell survival. In the other hand
overexpression of SOCS-1 in fibroblasts treated with IFN-γ and later infected with HSV1 decreased the fibroblast survival (27).
Although SOCS proteins have important role in inhibition of body’s anti viral
defense, it is not the only strategy employed by HSV-1. Rongtuanlin and colleagues (29)
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have demonstrated that other strategies can be used by HSV-1 to defeat body antiviral
defense, which is not IFN-γ dependent. They have shown that the HSV-1 immediate early
proteins ICP0 and virus shut off protein (vhs) together act against immune response (29).
Therefore, further studies are needed to verify which of these strategies are more
effective to block host immune response by HSV-1. This could be considered one
limitation on this approach and would be an appropriate subject for future studies.
Based on this study regarding the effect of IFN-γ and SOCS-1 role on HSV-1
reactivation and infection, I suggest using an appropriate mouse model such as the
corneal infection model of Frye and colleagues (30) in BALB/c or C3H mouse strains,
both of which are sensitive to HSV-1 infection . Keratinocyte and fibroblast cell cultures
of these strains were used by Frey and colleagues to show the efficacy of the IFN-γ
mimetic and SOCS-1 antagonist in inhibiting the cyptopathic effect of HSV-1, strain
17syn+ (27) in mouse keratinocytes. In my proposed experiment, both IFN-γ peptide
mimetic and SOCS-1 antagonist would be used as a drug therapy to reduce the number
of corneal lesions by 3-4 days after HSV-1 reactivation (31). In this experiment, mice
will be exposed to thermal stress (held for 10 minutes in a water-bath at 43 ° C) 28 days
after initial corneal infection (31) and subsequently, their corneas will be examine daily
for 5 days for the number of lesions. At the same time thermal stress is induced, the mice
will be administered (by oral or intraperitoneal route) SOCS-1 antagonist and INN-γ
peptide mimetic. This treatment will be repeated on day 2 and 4 after induction of
thermal stress. The mice will be examined daily for 5 days for the number of ocular
lesions. It is expected that reduced numbers of ocular leasions will be seen in comparison
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with control mice that had received thermal stress but no treatments. If so, the experiment
will be repeated and the trigeminal neurons will be removed from the mice in each of
these groups and examined immunohistochemically for the presence of phosphorylated
JAK2. This observation would confirm the cell culture observations of the molecular
events in which the IFN-γ peptide mimetic induces antiviral activity through binding to
intracellular domain of IFNGR1, and subsequently initiates autophosphorylation of
JAK2/STAT1α pathway (18, 19, And 20). In addition, SOCS-1 antagonist binds to KIR
region of SOCS-1 produced by virus and inhibits its activity.
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